Skip to main content
HANGZHOU FLARIANT CO., LTD logo

HANGZHOU FLARIANT CO., LTD — Investor Relations & Filings

Ticker · 605566 ISIN · CNE100004ZX6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 586 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 605566

About HANGZHOU FLARIANT CO., LTD

http://www.flariant.com/

Hangzhou Flariant Co., Ltd. specializes in the development and supply of high-performance colorants and chemical additives. The company’s core product range encompasses organic and inorganic pigments, solvent dyes, and optical brighteners designed for various industrial processes. These solutions are primarily utilized in the production of plastics, coatings, printing inks, and textiles. Flariant emphasizes technical precision and quality consistency, offering a broad spectrum of color solutions tailored to meet specific manufacturing standards. The company serves a global clientele, providing technical support and customized product formulations to ensure optimal performance in diverse material applications.

Recent filings

Filing Released Lang Actions
杭州福莱蒽特股份有限公司2026年第一次临时股东会会议资料
Regulatory Filings
2026-06-02 Chinese
杭州福莱蒽特股份有限公司关于2026年第一次临时股东会增加临时提案的公告
Proxy Solicitation & Information Statement Classification · 87% confidence The document is an official company announcement in China regarding an extraordinary shareholders meeting (EGM) and the addition of new proposals to be voted upon. It contains meeting details (date, record date, venue), a description of the added proposals, and includes a proxy authorization form for shareholders to submit their votes. It is a solicitation of proxies and information statement for a shareholders meeting, matching the “Proxy Solicitation & Information Statement” definition rather than a full financial report or vote results announcement. Therefore, it should be classified as PSI.
2026-05-29 Chinese
杭州福莱蒽特股份有限公司关于公司购买资产实施主体变更为子公司的公告
Regulatory Filings Classification · 78% confidence The document is a corporate announcement regarding the change of the implementation entity for an asset purchase to a newly formed wholly-owned subsidiary. It contains board resolutions, meeting dates, transaction size, and legal references, but it is not an annual or interim report, earnings release, share issue, merger filing, dividend notice, or other specific category. It is a general regulatory announcement about a corporate transaction, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-29 Chinese
杭州福莱蒽特股份有限公司关于新增公司及子公司2026年度申请银行授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company’s board regarding the addition of new bank credit facilities (up to RMB 20 billion) for the parent and subsidiaries, detailing board resolutions, approval process, credit line uses, and authorization for signing agreements. This is clearly an update on the company's financing activities (new credit lines), fitting the Capital/Financing Update category.
2026-05-29 Chinese
杭州福莱蒽特股份有限公司关于公司对外投资暨设立全资子公司的公告
Share Issue/Capital Change Classification · 65% confidence The document is a stock exchange announcement by a publicly listed company regarding its external investment and establishment of a wholly‐owned subsidiary, including the capital injection amount, structure and procedures. This is not a financial report (10-K, IR) nor a simple publication notice. It is specifically announcing a capital change (share capital increase) in the new subsidiary. Under our classification, this best fits “Share Issue/Capital Change (SHA)”.
2026-05-29 Chinese
杭州福莱蒽特股份有限公司关于新增2026年度对全资子公司担保额度的公告
Regulatory Filings Classification · 85% confidence The document is a formal exchange announcement detailing the board’s approval of increased guarantee limits for a wholly-owned subsidiary, including amounts, risk ratios, and required shareholder approval steps. It is not an annual or interim financial report, audit, proxy statement, dividend notice, or M&A transaction, nor does it present earnings results or ESG data. Instead, it is a routine regulatory disclosure under listing rules (no new securities issuance or direct financing event), making it a general regulatory filing. Therefore it falls under Regulatory Filings (RNS).
2026-05-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.